Prothena | PRTA - 流動資産





流動資産 変化する 日付
Acadia Pharmaceuticals USD 1.1B 33.9M 2026-03
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Akebia Therapeutics USD 243.48M 9.47M 2026-03
ALKERMES USD 1.36B 570.52M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Biogen USD 9.19B 216.3M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Exelixis USD 1.21B 234.65M 2026-03
Immunic USD 188.76M 165.89M 2026-03
Incyte USD 5.48B 460.36M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
MacroGenics USD 182.52M 37.42M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Prothena USD 339.2M 24.01M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xoma USD 110.71M 5.78M 2025-09